Current Report Filing (8-k)
15 Dezember 2015 - 12:03PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant
to Section 13 or 15(d)
of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): December 10, 2015
ARDELYX, INC.
(Exact
name of registrant as specified in its charter)
|
|
|
|
|
Delaware |
|
001-36485 |
|
26-1303944 |
(State or other jurisdiction
of incorporation) |
|
(Commission
File Number) |
|
(IRS Employer
Identification Number) |
34175 Ardenwood Blvd.
Fremont, CA 94555
(Address of principal executive offices, including Zip Code)
Registrants telephone number, including area code: (510) 745-1700
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the
following provisions:
¨ |
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
¨ |
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
¨ |
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
¨ |
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain
Officers; Compensatory Arrangements of Certain Officer.
On December 10, 2015, Peter G. Schultz, Ph.D., notified the Board of Directors of
Ardelyx, Inc. (the Company) of his decision to resign from the Board and the Compensation Committee of the Board, effective immediately, due to outside obligations. Dr. Schultz was recently appointed to serve as Chief
Executive Officer of Scripps Research Institute. Dr. Schultzs resignation is not due to any disagreement with the Company on any matter relating to the Companys operations, policies or practices.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
|
|
|
|
|
|
|
Date: December 14, 2015 |
|
|
|
ARDELYX, INC. |
|
|
|
|
|
|
|
|
By: |
|
/s/ Mark Kaufmann |
|
|
|
|
|
|
Mark Kaufmann |
|
|
|
|
|
|
Chief Financial Officer |
Ardelyx (NASDAQ:ARDX)
Historical Stock Chart
Von Jun 2024 bis Jul 2024
Ardelyx (NASDAQ:ARDX)
Historical Stock Chart
Von Jul 2023 bis Jul 2024